The Food and Drug Administration (FDA) just announced that over 580,000 bottles of blood pressure medications made by Teva ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives. United Therapeutics, a producer of gene-edited pig kidneys, ...

Parents and clinicians are urged to review usage of certain health products for young children after federal authorities ...

Prepared pasta sold at grocery chains across the country, including Albertsons and Trader Joe’s, were recalled after people ...

A "Super Greens" dietary supplement powder under the Member's Mark brand was recalled in connection with an ongoing ...

Boston-based Vertex reported revenue of $3.08 billion, an 11 percent gain from one year ago. That was ahead of analysts’ ...

Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...

Hims & Hers said that the discussions with Novo Nordisk (DK:NOVO.B) are ongoing, that "no definitive agreement" has been reached, and that the two companies may not reach one. Nonetheless, Hims & Hers ...

The FDA and CDC reported more deaths and illnesses in the ongoing listeria outbreak linked to ready-to-eat pasta products ...

Based on these scans, clinicians are able to assess fetal heartbeat, fetal movements, and amniotic fluid volume.

NEW YORK (Reuters) -Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's ...